THE USE OF CXCL12 FOR THERAPY AFTER PROSTATE SURGERY

• 收藏
• 分享

专利权人:

Wake Forest University Hralth Sciences

发明人:

James K. Williams

申请号：

US16637498

公开号：

US20200215160A1

申请日:

2018.08.10

申请国别(地区):

US

年份:

2020

代理人:

摘要：

This invention relates to C-X-C motif chemokine 12 (CXCL12), also known as stromal cell-derived factor 1 (SDF-1), vectors encoding the same, and methods of using the same for a male subject that has undergone prostate surgery to treat urological symptoms of the surgery.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/